BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31153048)

  • 1. Decreasing waiting time for treatment before and during implementation of cancer patient pathways in Norway.
    Nilssen Y; Brustugun OT; Tandberg Eriksen M; Gulbrandsen J; Skaaheim Haug E; Naume B; Møller B
    Cancer Epidemiol; 2019 Aug; 61():59-69. PubMed ID: 31153048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016.
    Nilssen Y; Brustugun OT; Eriksen MT; Guren MG; Haug ES; Naume B; Schlichting E; Møller B
    BMC Cancer; 2022 Feb; 22(1):220. PubMed ID: 35227226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
    Nilssen Y; Brustugun OT; Eriksen MT; Haug ES; Naume B; Møller B
    BMC Cancer; 2020 May; 20(1):488. PubMed ID: 32473650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UNOS OPTN waiting list: 1988-1995.
    Harper AM; Baker AS
    Clin Transpl; 1995; ():69-84. PubMed ID: 8794255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Waiting times for cancer care in four most frequent cancers in several French regions in 2011 and 2012].
    Pourcel G; Ledesert B; Bousquet PJ; Ferrari C; Viguier J; Buzyn A
    Bull Cancer; 2013 Dec; 100(12):1237-50. PubMed ID: 24158562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waiting for radiotherapy in Ontario.
    Mackillop WJ; Fu H; Quirt CF; Dixon P; Brundage M; Zhou Y
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):221-8. PubMed ID: 8083117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waiting times and treatment following cancer diagnosis: comparison between immigrants and the Norwegian host population.
    Thøgersen H; Møller B; Åsli LM; Bhargava S; Kvåle R; Fjellbirkeland L; Robsahm TE; Aaserud S; Babigumira R; Larsen IK
    Acta Oncol; 2020 Apr; 59(4):376-383. PubMed ID: 31920119
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathway times in the mammography programme before and after introduction of the breast cancer care pathway].
    Tsuruda KM; Bhargava S; Akslen LA; Bjørndal H; Hofvind S
    Tidsskr Nor Laegeforen; 2019 Sep; 139(12):. PubMed ID: 31502798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waiting times for cancer surgery in Ontario: 1984-2000.
    Bardell T; Belliveau P; Kong W; Mackillop WJ
    Clin Oncol (R Coll Radiol); 2006 Jun; 18(5):401-9. PubMed ID: 16817332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy wait times for patients with a diagnosis of invasive cancer, 1992-2000.
    Johnston GM; MacGarvie VL; Elliott D; Dewar RA; MacIntyre MM; Nolan MC
    Clin Invest Med; 2004 Jun; 27(3):142-56. PubMed ID: 15305806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Waiting time for surgery of lung cancer].
    Strand TE; Rostad H; Sørum R; Solberg S; Norstein J
    Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1894-7. PubMed ID: 16915309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival.
    van Harten MC; Hoebers FJ; Kross KW; van Werkhoven ED; van den Brekel MW; van Dijk BA
    Oral Oncol; 2015 Mar; 51(3):272-8. PubMed ID: 25541458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The UNOS OPTN (Organ Procurement and Transplantation Network) waiting list: 1988 through November 30, 1992.
    Edwards EB; Breen TJ; Guo T; Ellison MD; Daily OP
    Clin Transpl; 1992; ():61-75. PubMed ID: 1306723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient experiences of waiting times in standardised cancer patient pathways in Norway - a qualitative interview study.
    Solbjør M; Sand K; Ervik B; Melby L
    BMC Health Serv Res; 2021 Jul; 21(1):651. PubMed ID: 34225705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waiting time for breast cancer surgery in Quebec.
    Mayo NE; Scott SC; Shen N; Hanley J; Goldberg MS; MacDonald N
    CMAJ; 2001 Apr; 164(8):1133-8. PubMed ID: 11338798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000.
    Simunovic M; Thériault ME; Paszat L; Coates A; Whelan T; Holowaty E; Levine M
    Can J Surg; 2005 Apr; 48(2):137-42. PubMed ID: 15887794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of age and diagnosis on waiting times between important healthcare events among children 0 to 19 years cared for in pediatric units: the Canadian Childhood Cancer Surveillance and Control Program.
    Klein-Geltink J; Pogany L; Mery LS; Barr RD; Greenberg ML
    J Pediatr Hematol Oncol; 2006 Jul; 28(7):433-9. PubMed ID: 16825989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waiting times for radiotherapy: variation over time and between cancer networks in southeast England.
    Robinson D; Massey T; Davies E; Jack RH; Sehgal A; Møller H
    Br J Cancer; 2005 Apr; 92(7):1201-8. PubMed ID: 15785752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of waiting times for the 4 most prevalent cancer types in Ontario: a retrospective population-based analysis.
    Rastpour A; Begen MA; Louie AV; Zaric GS
    CMAJ Open; 2018; 6(2):E227-E234. PubMed ID: 29880658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.